The Zinzino October 2025 Preliminary Sales Report paints a remarkable picture of transformation and expansion for the Scandinavian wellness company. With a 65% year-over-year increase, Zinzino’s revenue soared to SEK 327.5 million, up from SEK 198.9 million in October 2024. Year-to-date revenues climbed an equally impressive 55%, reaching SEK 2.63 billion, reflecting both organic growth and the impact of well-executed acquisitions.
This achievement cements Zinzino’s reputation as a rising global leader in personalized nutrition and direct sales wellness, now active in more than 100 markets worldwide.
Highlights from the October 2025 Preliminary Report
Â
Â
Â
Zinzino’s momentum showcases its ability to scale effectively while diversifying its portfolio.
Understanding Zinzino’s Global Business Model
Founded in Sweden, Zinzino AB (ZZ-B.ST) operates on a direct-selling model focused on test-based nutrition, an approach combining science-driven personalization with consumer empowerment. By integrating R&D and manufacturing capabilities (via subsidiaries like Faun Pharma and BioActive Foods AS), Zinzino maintains a high degree of quality control and innovation speed.
The Nordics, Zinzino’s foundational region, reported SEK 36.3M in October 2025 revenue, up 24% YoY, maintaining steady progress in a mature market. Year-to-date growth stood at 11%, reflecting continued loyalty among its core consumer base.
Central Europe: A Strong Performance Driven by New Demand
Central Europe delivered an 88% monthly increase, reaching SEK 101.3M, with YTD figures jumping 69%. This growth underscores successful expansion in key countries like Germany, Austria, and Switzerland.Eastern Europe: Market Saturation and Flat Performance
Eastern Europe was the only stagnant performer, recording 0% growth in October and a slight 1% YTD decline. This may indicate market saturation or emerging regulatory barriers.
South & West Europe: Expanding Core Consumer Base
The region achieved a 56% monthly and 51% YTD growth, signaling growing brand recognition and distributor network effectiveness in Spain, Italy, and France.
The Baltics: Steady Expansion with Room for Growth
At +29% monthly and +24% YTD, the Baltics remain a dependable growth region, supported by strong local partnerships.
North America: Explosive Growth Fueled by Strategic Acquisitions
Zinzino’s North American market saw 167% growth in October and 183% YTD, propelled by acquisitions of Truvy and Bodē Pro, two US-based wellness companies with established customer networks.
Asia-Pacific: The Star Performer of 2025
Asia-Pacific surged 384% in October and 353% YTD, emerging as Zinzino’s most dynamic region. This reflects a successful entry into high-potential markets like India, the Philippines, Thailand, and Singapore.
Africa: Emerging Market with Promising Potential
With 35% monthly and 45% YTD growth, Africa remains small in absolute terms but demonstrates potential for future expansion as infrastructure and digital commerce improve.
Zinzino’s aggressive acquisition strategy, including Truvy, Valentus, Bodē Pro, Zurvita, and Xelliss, has diversified its product lines and expanded market reach. These moves also support cross-selling opportunities across regions.
Strategic Benefits:
However, acquisitions also bring integration challenges, especially in aligning different brand identities under one cohesive corporate strategy.
Test-Based Nutrition: A Competitive Edge
Zinzino’s cornerstone is its test-based nutrition system, allowing customers to tailor supplement intake based on blood analysis. This scientific approach has fueled trust and retention, distinguishing the brand from traditional MLM models.
Expansion of Skincare Line: HANZZ+HEIDII’s Contribution
Zinzino’s skincare arm, HANZZ+HEIDII, continues to gain traction, aligning with consumer trends favoring holistic wellness, combining inner and outer health.
Decline in Faun Pharma Performance
Faun Pharma’s sharp decline (-63% MoM, -51% YTD) raises questions about internal restructuring or a pivot away from external contract manufacturing to prioritize in-house production.
Regulatory and Supply Chain Pressures
Rapid global expansion, especially in Asia and North America, exposes Zinzino to varying regulatory landscapes and supply chain complexities. Effective compliance and localization strategies will be essential.
Balancing Acquisitions with Sustainable Growth
While acquisitions have accelerated growth, maintaining brand coherence and profitability amid expansion remains a key challenge.
Key Revenue and YTD Figures Explained
Zinzino’s financials for October 2025 highlight robust operational scaling and a sharp shift in geographical balance.
Here’s a closer look:
Region | Oct 2025 (SEK M) | Oct 2024 (SEK M) | YoY Change | YTD 2025 (SEK M) | YTD 2024 (SEK M) | YTD Change |
The Nordics | 36.3 | 29.3 | +24% | 270.3 | 243.3 | +11% |
Central Europe | 101.3 | 53.9 | +88% | 758.9 | 448.3 | +69% |
East Europe | 34.4 | 34.5 | 0% | 310.3 | 314.4 | -1% |
South/West Europe | 57.8 | 37.0 | +56% | 455.8 | 301.5 | +51% |
The Baltics | 13.0 | 10.1 | +29% | 98.2 | 79.5 | +24% |
North America | 51.6 | 19.3 | +167% | 433.6 | 153.3 | +183% |
Asia-Pacific | 28.1 | 5.8 | +384% | 241.3 | 53.3 | +353% |
Africa | 2.3 | 1.7 | +35% | 18.3 | 12.6 | +45% |
Zinzino Total | 324.8 | 191.6 | +70% | 2586.7 | 1606.2 | +61% |
Faun Pharma | 2.7 | 7.3 | -63% | 43.0 | 87.0 | -51% |
Group Total | 327.5 | 198.9 | +65% | 2629.7 | 1693.2 | +55% |
This data reflects not just a surge in sales, but also a strategic realignment of Zinzino’s revenue mix, shifting away from traditional European reliance to global diversification.
The geographical diversification of Zinzino’s revenue base acts as both a risk hedge and a growth amplifier. With Asia-Pacific and North America now accounting for a substantial portion of total sales, Zinzino has effectively:
This pivot underscores the company’s long-term ambition to transition from a Nordic brand to a truly global health-tech enterprise.
Zinzino’s 2025 trajectory offers valuable lessons for the broader direct-sales and wellness sectors. By leveraging scientific personalization, acquisitions, and digital scalability, Zinzino is redefining what a modern direct-selling company can achieve.
Comparing Zinzino’s Growth Model to Competitors
While many traditional direct-selling companies face stagnation, Zinzino’s success lies in:
In contrast, competitors like Herbalife and Amway continue to rely heavily on legacy distribution and less personalized approaches.
How Data-Driven Personalization Is Shaping Consumer Trends
Consumers are increasingly seeking tailored wellness solutions. Zinzino’s approach to testing, tracking, and adjusting supplementation aligns with this global shift.
This consumer trend is expected to grow exponentially through 2030, as AI and biofeedback tools become integrated with wellness offerings.
While Zinzino’s growth story is extraordinary, it’s not without risks.
Zinzino’s ability to manage these pressures will determine whether this growth is structural or cyclical.
The Strategic Path Ahead for 2026 and Beyond
Looking forward, Zinzino’s next phase of growth will likely focus on:
Additionally, as the global demand for preventive health and longevity solutions rises, Zinzino’s science-backed approach gives it a defensible niche in an otherwise crowded market.
Investor Sentiment and Market Expectations
Market sentiment remains optimistic. Analysts expect Zinzino to sustain double-digit growth through 2026, driven by recurring subscription models and global expansion. However, investors will monitor the company’s profit margins, particularly as integration costs from acquisitions start to normalize.
The Zinzino October 2025 Preliminary Sales Report marks a defining moment in the company’s evolution from a Nordic direct-seller to a global wellness innovator. With strategic acquisitions, scientific personalization, and regional diversification, Zinzino has built a solid foundation for sustainable expansion.
While challenges like integration complexity and regulatory compliance persist, Zinzino’s adaptability, leadership, and product innovation set it apart in an increasingly competitive wellness market.
Get more information
There are no reviews yet. Be the first one to write one.
